David Elliott, MD, board-certified in gastroenterology and internal medicine, will be speaking at the April 9 Coronado Biosciences Analyst Event in New York, according to a NASDAQ report.
Coronado Biosciences is a pharmaceutical company that develops biologic treatments for cancer and autoimmune diseases. The April 9 event will feature several physician experts speaking on inflammatory bowel disease, immunology, type 1 diabetes, psoriasis and autism.
Dr. Elliott is the James A. Clifton Chair of Gastroenterology and director of the gastroenterology and hepatology division at the University of Iowa Carver College of Medicine in Iowa City.
More Articles on Gastroenterology:
Apollo Endosurgery Receives CE Mark for Endoscopic Suturing Device
UW Health Opens $21M Digestive Center in Madison
8 Revenue Statistics for GI-Driven ASCs
Coronado Biosciences is a pharmaceutical company that develops biologic treatments for cancer and autoimmune diseases. The April 9 event will feature several physician experts speaking on inflammatory bowel disease, immunology, type 1 diabetes, psoriasis and autism.
Dr. Elliott is the James A. Clifton Chair of Gastroenterology and director of the gastroenterology and hepatology division at the University of Iowa Carver College of Medicine in Iowa City.
More Articles on Gastroenterology:
Apollo Endosurgery Receives CE Mark for Endoscopic Suturing Device
UW Health Opens $21M Digestive Center in Madison
8 Revenue Statistics for GI-Driven ASCs